Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation.
Initiating events leading to the accumulation of malignant ascites in the peritoneal cavity were investigated in two syngeneic transplantable murine ascites-producing tumors, MOT mouse ovarian tumor and the TA3/St mammary carcinoma. The transport of two tracers, 125I-labeled human serum albumin (125I-HSA) and 51Cr-labeled red blood cells (51Cr-RBC), into and out of the peritoneal cavity was studied at early times after i.p. tumor cell injection, prior to abundant fluid accumulation, and at intervals of 5 to 360 min after i.v. or i.p. tracer injection. Tracer influx and efflux rates were estimated from the mass of tracer passing into or out of the peritoneal cavity following a bolus injection of tracer into either the blood or the peritoneal cavity. Efflux of 125I-HSA from the peritoneal cavity was markedly reduced (3- to 5-fold) within 1 day of i.p. injection of either type of tumor cell. Significantly reduced efflux preceded any increase in tumor cell number and by itself did not induce peritoneal fluid accumulation. 125I-HSA tracer influx from plasma to peritoneal fluid did not increase detectably until 5 to 7 days after tumor cell injection, when the tumor cell number had increased by 10- to 100-fold. Only at relatively late stages of ascites tumor growth, when the flow rate into the peritoneal cavity had increased relative to the flow rate out of the peritoneum, was there net peritoneal fluid accumulation. Thus, increased influx, in addition to impaired efflux, were required for malignant ascites accumulation. Following i.p. injection, the efflux rates of 125I-HSA always exceeded those of 51Cr-RBC, even in ascites tumor-bearing animals. Furthermore, 125I-HSA tracer disappeared from the peritoneal cavity more rapidly than it appeared in the plasma, suggesting that 125I-HSA moves more rapidly through the channels by which 51Cr-RBC egress from the peritoneum (primarily diaphragmatic lymphatics) and/or has access to additional pathways not open to 51Cr-RBC. Finally, flow rates into and out of the blood and peritoneum were used to obtain kinetic parameters that characterized tracer transport: k1, the rate constant for tracer transport from the blood to the peritoneum; k2, the rate constant for tracer transport from the peritoneal cavity to the blood; and k6, the rate constant for tracer transport from the peritoneal cavity to surrounding interstitial tissue.(ABSTRACT TRUNCATED AT 400 WORDS)
Nagy
J A
JA
Department of Pathology, Beth Israel Hospital, Boston, Massachusetts 02215.
Herzberg
K T
KT
Dvorak
J M
JM
Dvorak
H F
HF
D000818:Animals; D001201:Ascites / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D001202:Ascitic Fluid / Q000378:metabolism*; D002860:Chromium Radioisotopes / Q000378:metabolism; D004912:Erythrocytes / Q000000981:diagnostic imaging; D005260:Female; D007457:Iodine Radioisotopes / Q000378:metabolism; D015674:Mammary Neoplasms, Animal / Q000150:complications / Q000378:metabolism*; D051379:Mice; D008805:Mice, Inbred A; D008809:Mice, Inbred C3H; D010051:Ovarian Neoplasms / Q000150:complications / Q000378:metabolism*; D011877:Radionuclide Imaging; D012709:Serum Albumin / Q000378:metabolism; D012710:Serum Albumin, Bovine / Q000378:metabolism
D002860:Chromium Radioisotopes; D007457:Iodine Radioisotopes; D012709:Serum Albumin; D012710:Serum Albumin, Bovine